DK157540C - METHOD OF ANALOGUE FOR THE PREPARATION OF SECONDARY 2-AMINOALKYL-5-PYRIDINOLS OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS. - Google Patents

METHOD OF ANALOGUE FOR THE PREPARATION OF SECONDARY 2-AMINOALKYL-5-PYRIDINOLS OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.

Info

Publication number
DK157540C
DK157540C DK193180A DK193180A DK157540C DK 157540 C DK157540 C DK 157540C DK 193180 A DK193180 A DK 193180A DK 193180 A DK193180 A DK 193180A DK 157540 C DK157540 C DK 157540C
Authority
DK
Denmark
Prior art keywords
formula
preparation
xii
pyridinols
aminoalkyl
Prior art date
Application number
DK193180A
Other languages
Danish (da)
Other versions
DK193180A (en
DK157540B (en
Inventor
Renat Herbert Mizzoni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK193180A publication Critical patent/DK193180A/en
Publication of DK157540B publication Critical patent/DK157540B/en
Application granted granted Critical
Publication of DK157540C publication Critical patent/DK157540C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Building Environments (AREA)
  • Paper (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

There is described a process for preparing an enamine of formula (IX): <IMAGE> where R<2> is a carboxylic acid protecting group and R<3> is the residue of a carboxylic acid derived acyl group and where R<5> and R<6> are the same or different C1-4 alkyl or C1-10 aralkyl groups; or taken together with the adjacent nitrogen atom form a heterocyclic ring containing from 4 to 8 carbon atoms and optionally a further heteroatom selected from oxygen and nitrogen; by reacting a compound of formula (XII): <IMAGE> with an amine of formula HNR<5>R<6>, the reactant of formula (XII) being prepared by reaction of an appropriate enol derivative with a phosphorus reagent. The enamines of formula (IX) are useful in the preparation of 3- hydroxycephalosporins. The compounds of formula (XII) are novel.
DK193180A 1979-05-03 1980-05-01 METHOD OF ANALOGUE FOR THE PREPARATION OF SECONDARY 2-AMINOALKYL-5-PYRIDINOLS OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS. DK157540C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3566879A 1979-05-03 1979-05-03
US3566879 1979-05-03

Publications (3)

Publication Number Publication Date
DK193180A DK193180A (en) 1980-11-04
DK157540B DK157540B (en) 1990-01-22
DK157540C true DK157540C (en) 1990-06-11

Family

ID=21884070

Family Applications (1)

Application Number Title Priority Date Filing Date
DK193180A DK157540C (en) 1979-05-03 1980-05-01 METHOD OF ANALOGUE FOR THE PREPARATION OF SECONDARY 2-AMINOALKYL-5-PYRIDINOLS OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.

Country Status (19)

Country Link
EP (1) EP0019739B1 (en)
JP (1) JPS55149260A (en)
AT (1) ATE8501T1 (en)
DD (1) DD150461A5 (en)
DE (1) DE3068577D1 (en)
DK (1) DK157540C (en)
ES (1) ES491055A0 (en)
FI (1) FI70212C (en)
GB (1) GB2050380B (en)
GR (1) GR68206B (en)
HU (1) HU181115B (en)
IE (1) IE49712B1 (en)
IL (1) IL59978A (en)
MA (1) MA18964A1 (en)
NO (1) NO154130C (en)
OA (1) OA06528A (en)
PL (1) PL223984A1 (en)
PT (1) PT71176A (en)
ZW (1) ZW9680A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746670A (en) * 1986-04-11 1988-05-24 Ciba-Geigy Corporation Use of 2-aminoalkyl-5-pyridinols as nootropic agents and antidepressants
JP4732662B2 (en) * 2000-04-06 2011-07-27 セイコーインスツル株式会社 Battery holding structure for electronic watch

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
DK193180A (en) 1980-11-04
FI70212C (en) 1986-09-15
IL59978A0 (en) 1980-07-31
ATE8501T1 (en) 1984-08-15
IE49712B1 (en) 1985-11-27
GR68206B (en) 1981-11-10
OA06528A (en) 1981-07-31
FI801411A (en) 1980-11-04
JPS6365662B2 (en) 1988-12-16
PT71176A (en) 1980-05-01
ES8104229A1 (en) 1981-04-01
EP0019739B1 (en) 1984-07-18
HU181115B (en) 1983-06-28
DK157540B (en) 1990-01-22
GB2050380A (en) 1981-01-07
DE3068577D1 (en) 1984-08-23
JPS55149260A (en) 1980-11-20
ZW9680A1 (en) 1980-11-26
GB2050380B (en) 1983-07-20
DD150461A5 (en) 1981-09-02
NO801267L (en) 1980-11-04
NO154130C (en) 1986-07-23
IL59978A (en) 1984-03-30
MA18964A1 (en) 1980-12-31
IE800899L (en) 1980-11-03
EP0019739A1 (en) 1980-12-10
PL223984A1 (en) 1981-02-13
FI70212B (en) 1986-02-28
NO154130B (en) 1986-04-14
ES491055A0 (en) 1981-04-01

Similar Documents

Publication Publication Date Title
DE3363244D1 (en) Compounds, process for their preparation and their use as pharmaceutical preparations
DK182081A (en) PROCEDURE FOR THE PREPARATION OF HYDROXAMIC ACIDS
ES469953A1 (en) Novel aminoalkylbenzene derivative process for preparing same medical composition and application thereof
ES2000604A6 (en) Process for the preparation of aryl-piperidine esters.
GB1434323A (en) N-acylated substituted piperazine or homopiperazine derivatives and processes for their preparation
DK157540C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF SECONDARY 2-AMINOALKYL-5-PYRIDINOLS OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
ES8104309A1 (en) Process for preparing enamine derivatives, compounds so produced and process for preparing a 3-hydroxy-cephalosporin.
ES8200681A1 (en) Process for preparing derivatives of 5,11-dihydro-6h-pyrido[2,3-b][1,4]-benzodiazepin-6-one, and the final derivatives and synthesis intermediates obtained thereby
DK148804C (en) METHOD FOR PREPARING 1,2,3,4-TETRAHYDROQUINOLIN-4-ONER
FI873443A (en) NORFLOXACINMELLANPRODUKT.
GB1008849A (en) Basically substituted triazolidines, processes for their manufacture and pharmaceutical preparations containing them
ES8401059A1 (en) Bicyclic phenol ethers, process for their preparation and medicines containing these compounds.
SE8301785L (en) SET TO MAKE 2-THIOPHENIC ACETIC ACID DERIVATIVES AND INTERMEDIATES REQUIRED FOR THEIR PREPARATION
GB871235A (en) Novel substituted pyrrolidones and salts thereof and a process for the manufacture of same
DK501482A (en) METHOD FOR PREPARING CARBOXYLIC ACID ANHYDRIDES
ES451113A1 (en) Improvement of organic compound
DK145948C (en) PROCEDURE FOR PREPARING SULPHONIMIDOYLXANTHON-2-CARBOXYLIC ACID DERIVATIVES
ES473484A1 (en) A procedure for the preparation of new eteres of the clavulan acid (Machine-translation by Google Translate, not legally binding)
ES8600762A1 (en) Beta-lactam compounds.

Legal Events

Date Code Title Description
PBP Patent lapsed